Skip to content
DataLookout
Menu

CIPHERNCT06480760

Effects of Carnosine In Patients With Peripheral Arterial Disease Patients

StatusRecruiting
PhasePhase 1/2
Primary completion (estimated)

At risk: Enrollment reduced 17%.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 7 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 66 words Show 5 more changesShow less
    • Enrollment reduced: 144 → 120 participants
    • Secondary endpoints: details revised at 18 of 19 entries
    • Study description revised
    • Site contacts updated at 1 of 3 sites
    • Publications: details revised at 36 of 39 entries
  2. Notable Primary and study completion dates: Aug 1, 2027 to Oct 1, 2028v6 Show 7 more changesShow less
    • Eligibility criteria expanded, about 55 words
    • Primary endpoints: 17 to 1
    • Enrollment target: 120 to 144
    • Study sites: 1 to 3
    • Start date: May 1, 2025 to May 20, 2025
    • Secondary endpoints expanded, about 65 words
    • Study description shortened, about 14 words
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Feb 1, 2025 to May 1, 2025
    • Study description revised
    • Site details revised
    v5
  4. Notable Start date: Aug 1, 2024 to Feb 1, 2025
    • Eligibility criteria revised
    • Collaborators expanded, about 12 words
    v4
  5. Notable Eligibility criteria revisedv3
  6. Notable Phase: Phase 3 to Phase 1/2
    • Study title shortened, about 4 words
    v2
  7. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Measure distance covered on six-minute walk test (6MWT)
Timeframe: Baseline, 3 months, 6 months, 9 months

Secondary (18)

Measure Ankle-Brachial Index (ABI)
Treadmill Testing
Skin Integrity
Musculoskeletal Assessment
Neuromuscular Assessment
Show 13 moreShow less
Balance Assessment
Quality of life Questionnaire
Assessment of PAD Severity
Depressive Symptoms Questionnaire
24-hour Dietary Recall
Daily Walking Ability
Blood Collection and Analysis
Measurement of Carnosine in Blood and Urine
Measure Angiogenic Cell Population
Mitochondrial Abundance Measurements
Measurement of Carnosine in Muscle
Measurement of Blood Flow
Calf Muscle Biopsy

Arms and interventions

PlaceboNo intervention

Cellulose

CarnosineExperimental

Carnosine 2 g daily for 6 months

Drugs: Carnosine

Sites

3 sites in 1 country